← Eichor
Condition: Breast Cancer Liquid Biopsy Early Detection Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Breast Cancer Liquid Biopsy Early Detection

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Clinical Validation of Early Detection Blood Test for Universal Large-scale Breast Cancer Screening
Phase N/A · 4 location(s) · Syantra Inc. · NCT07219277Evaluation of Circulating Tumor Cells (CTC) Relevance in Breast Cancer Follow-up Using the ScreenCell Device
NA · 1 location(s) · ScreenCell · NCT06807502Validation of the Oncoliq Test for the Early Detection of Breast Cancer.
Phase N/A · 1 location(s) · Oncoliq US Inc · NCT07331506cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Phase N/A · 17 location(s) · Adela, Inc · NCT05366881CfDNA in Hereditary And High-risk Malignancies 2
Phase N/A · 8 location(s) · University Health Network, Toronto · NCT06726642CtDNA Based MRD Testing for NAC Monitoring in TNBC
Phase N/A · 14 location(s) · Personalis Inc. · NCT06230185
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.